• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆管癌:应对这一具有挑战性癌症的新方法

Cholangiocarcinoma: emerging approaches to a challenging cancer.

作者信息

Patel Tushar, Singh Pankaj

机构信息

Department of Internal Medicine,Scott and White Clinic, Texas A&M University Health Science Center, Temple, TX 76508, USA.

出版信息

Curr Opin Gastroenterol. 2007 May;23(3):317-23. doi: 10.1097/MOG.0b013e3280495451.

DOI:10.1097/MOG.0b013e3280495451
PMID:17414849
Abstract

PURPOSE OF REVIEW

Cholangiocarcinomas are malignancies arising from biliary tract epithelia that are associated with a poor prognosis. The diagnosis, evaluation and management of these tumors continue to be clinically challenging. In this review, we will discuss recent information that may influence the approach to the diagnosis and management of this devastating tumor.

RECENT FINDINGS

Epidemiological studies are defining patient groups at increased risk of cancer in regions of low prevalence. Emerging approaches that may improve evaluation and management include the potential use of genomic and proteomic markers, cytogenetic and digital image analysis, endoscopic ultrasound with fine needle aspiration, and cholangioscopy. Adoption of aggressive surgical approaches along with the use of preoperative portal vein embolization, hepatic and caudate lobe resection and preoperative laparoscopy may improve survival.

SUMMARY

Recent conceptual and technical advances will impact the clinical approach to cholangiocarcinoma and offer the promise of improving outcomes from this difficult tumor.

摘要

综述目的

胆管癌是起源于胆道上皮的恶性肿瘤,预后较差。这些肿瘤的诊断、评估和管理在临床上仍然具有挑战性。在本综述中,我们将讨论可能影响这种毁灭性肿瘤诊断和管理方法的最新信息。

最新发现

流行病学研究正在确定低发病率地区癌症风险增加的患者群体。可能改善评估和管理的新兴方法包括基因组和蛋白质组标志物的潜在应用、细胞遗传学和数字图像分析、超声内镜引导下细针穿刺以及胆管镜检查。采用积极的手术方法,同时使用术前门静脉栓塞、肝叶和尾状叶切除以及术前腹腔镜检查可能会提高生存率。

总结

最近的概念和技术进展将影响胆管癌的临床治疗方法,并有望改善这种难治性肿瘤的治疗效果。

相似文献

1
Cholangiocarcinoma: emerging approaches to a challenging cancer.胆管癌:应对这一具有挑战性癌症的新方法
Curr Opin Gastroenterol. 2007 May;23(3):317-23. doi: 10.1097/MOG.0b013e3280495451.
2
[Hepatocellular carcinoma and cholangiocarcinoma].[肝细胞癌和胆管癌]
Chirurg. 2010 Oct;81(10):941-52; quiz 953. doi: 10.1007/s00104-009-1864-z.
3
AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review.AGA 临床实践更新:原发性硬化性胆管炎患者肝胆癌监测:专家综述。
Clin Gastroenterol Hepatol. 2019 Nov;17(12):2416-2422. doi: 10.1016/j.cgh.2019.07.011. Epub 2019 Jul 12.
4
The role of portal vein embolization in the surgical management of primary hepatobiliary cancers. A systematic review.门静脉栓塞在原发性肝胆癌手术治疗中的作用。一项系统评价。
Eur J Surg Oncol. 2017 Jan;43(1):32-41. doi: 10.1016/j.ejso.2016.05.026. Epub 2016 Jun 1.
5
Successful diagnosis and resection of icteric type hepatocellular carcinoma.黄疸型肝细胞癌的成功诊断与切除
Hepatogastroenterology. 2003 Sep-Oct;50(53):1634-6.
6
Diagnostic approaches for cholangiocarcinoma.胆管癌的诊断方法。
World J Gastroenterol. 2008 Jul 14;14(26):4131-6. doi: 10.3748/wjg.14.4131.
7
Endoscopic tissue diagnosis of cholangiocarcinoma.胆管癌的内镜组织诊断
Curr Opin Gastroenterol. 2008 Sep;24(5):627-30. doi: 10.1097/MOG.0b013e32830bf7e1.
8
Imaging of malignancies of the biliary tract- an update.胆道恶性肿瘤的影像学——最新进展
Cancer Imaging. 2014 Apr 22;14(1):14. doi: 10.1186/1470-7330-14-14.
9
Synchronous cancers of gallbladder carcinoma and combined hepatocellular cholangiocarcinoma: an unusual case and literature review.胆囊癌合并肝细胞癌:一种不常见的病例并文献复习。
BMC Cancer. 2018 Oct 29;18(1):1046. doi: 10.1186/s12885-018-4969-2.
10
Hepatocellular carcinoma: latest developments.肝细胞癌:最新进展
Curr Opin Gastroenterol. 2008 May;24(3):312-9. doi: 10.1097/MOG.0b013e3282fafef3.

引用本文的文献

1
Complex Interventions for Cancer and Cholangiocarcinoma: A Systematic Review and Applications for Public Education.癌症和胆管癌的复杂干预措施:系统评价及对公众教育的应用
J Cancer Educ. 2025 Sep 12. doi: 10.1007/s13187-025-02705-z.
2
Therapeutic Implications of Ceritinib in Cholangiocarcinoma beyond ALK Expression and Mutation.色瑞替尼在胆管癌中超出ALK表达和突变的治疗意义
Pharmaceuticals (Basel). 2024 Feb 2;17(2):197. doi: 10.3390/ph17020197.
3
Postoperative Prognostic Predictors of Bile Duct Cancers: Clinical Analysis and Immunoassays of Tissue Microarrays.
胆管癌的术后预后预测因子:组织微阵列的临床分析和免疫测定。
Gut Liver. 2023 Jan 15;17(1):159-169. doi: 10.5009/gnl220044. Epub 2022 Nov 1.
4
Genomic alterations in cholangiocarcinoma: clinical significance and relevance to therapy.胆管癌中的基因组改变:临床意义及其与治疗的相关性。
Explor Target Antitumor Ther. 2022;3(2):200-223. doi: 10.37349/etat.2022.00079. Epub 2022 Apr 26.
5
Co-Clinical Trials: An Innovative Drug Development Platform for Cholangiocarcinoma.联合临床试验:胆管癌的创新药物研发平台
Pharmaceuticals (Basel). 2021 Jan 11;14(1):51. doi: 10.3390/ph14010051.
6
Outcomes after vascular resection during curative-intent resection for hilar cholangiocarcinoma: a multi-institution study from the US extrahepatic biliary malignancy consortium.肝门部胆管癌根治性切除术中血管切除后的结局:美国肝外胆管恶性肿瘤联盟的一项多机构研究
HPB (Oxford). 2018 Apr;20(4):332-339. doi: 10.1016/j.hpb.2017.10.003. Epub 2017 Nov 21.
7
Imaging of Cholangiocarcinoma.胆管癌的影像学检查
Visc Med. 2016 Dec;32(6):402-410. doi: 10.1159/000453009. Epub 2016 Dec 6.
8
Causes of hepatic capsular retraction: a pictorial essay.肝包膜回缩的原因:图文综述
Insights Imaging. 2016 Dec;7(6):831-840. doi: 10.1007/s13244-016-0520-7. Epub 2016 Sep 29.
9
Validation of the EORTC QLQ-BIL21 questionnaire for measuring quality of life in patients with cholangiocarcinoma and cancer of the gallbladder.欧洲癌症研究与治疗组织QLQ-BIL21问卷用于测量胆管癌和胆囊癌患者生活质量的效度验证。
Br J Cancer. 2016 Oct 25;115(9):1032-1038. doi: 10.1038/bjc.2016.284. Epub 2016 Sep 27.
10
Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma.血清微小RNA作为原发性硬化性胆管炎和胆管癌的新型生物标志物。
Clin Exp Immunol. 2016 Jul;185(1):61-71. doi: 10.1111/cei.12776. Epub 2016 May 17.